Close

Analyst Ratings for Homology Medicines (FIXX) [Neutrals]

FIXX Rating Summary

FIXX Price Target Summary

* Over Last 12-Mos
  |   Expand Research on FIXX
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $6.89 (+344.3%) * Over Last 12-Mos
Rating Score: 6.2 / 10   Percentile Rank: 64%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
4/28/2022 Credit Suisse
» Updated 8/16/2022
Richard Law New Coverage Neutral
(N/A)
3.21
(3.10)
1.61
(1.55)
-3.73% Details
2/22/2022 RBC Capital
» Updated 11/11/2022
Luca Issi Downgrade Sector Perform
(Outperform)
3.00
(4.00)
3.86
(1.55)
-59.84% Details
Like FIXX Ratings? Also take a look at VRT, EMBK, VLTA, FAT

FIXX Ratings News